Biomarkers and surrogate endpoints in the glaucomatous optic neuropathy: new developments and a review
Autor(a) principal: | |
---|---|
Data de Publicação: | 2015 |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Revista Brasileira de Oftalmologia (Online) |
Texto Completo: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0034-72802015000400257 |
Resumo: | ABSTRACT Glaucoma is a group of progressive optic neuropathies that have in common a slow progressive degeneration of retinal ganglion cells and their axons, resulting in a distinct appearance of the optic disc and a concomitant pattern of visual loss. Biomarkers are characteristics objectively measured and evaluated as indication of normal biologic processes, pathogenic processes, or pharmacologic responses to a therapeutic intervention. Several biological markers have been implicated with glaucoma, especially genetics, proteomics, autoimmune and other molecular biomarkers, although, most awaits clinical validation. There are clear potential benefits in using biomarkers. Information can be obtained earlier, faster, and less costly. This review summarizes the latest developments and approaches in glaucoma biomarkers and its possible uses in the diagnosis, staging, and as predictors of response to treatment. |
id |
SBO-1_dd95822da2dbe48782fcd4d81e45ecf1 |
---|---|
oai_identifier_str |
oai:scielo:S0034-72802015000400257 |
network_acronym_str |
SBO-1 |
network_name_str |
Revista Brasileira de Oftalmologia (Online) |
repository_id_str |
|
spelling |
Biomarkers and surrogate endpoints in the glaucomatous optic neuropathy: new developments and a reviewGlaucomaOptic nerve diseasesBiological makersGlaucomaDoenças do nervo ópticoMarcadores biológicosABSTRACT Glaucoma is a group of progressive optic neuropathies that have in common a slow progressive degeneration of retinal ganglion cells and their axons, resulting in a distinct appearance of the optic disc and a concomitant pattern of visual loss. Biomarkers are characteristics objectively measured and evaluated as indication of normal biologic processes, pathogenic processes, or pharmacologic responses to a therapeutic intervention. Several biological markers have been implicated with glaucoma, especially genetics, proteomics, autoimmune and other molecular biomarkers, although, most awaits clinical validation. There are clear potential benefits in using biomarkers. Information can be obtained earlier, faster, and less costly. This review summarizes the latest developments and approaches in glaucoma biomarkers and its possible uses in the diagnosis, staging, and as predictors of response to treatment.Sociedade Brasileira de Oftalmologia2015-08-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0034-72802015000400257Revista Brasileira de Oftalmologia v.74 n.4 2015reponame:Revista Brasileira de Oftalmologia (Online)instname:Sociedade Brasileira de Oftalmologia (SBO)instacron:SBO10.5935/0034-7280.20150054info:eu-repo/semantics/openAccessKasahara,Niroeng2015-11-26T00:00:00Zoai:scielo:S0034-72802015000400257Revistahttps://rbo.emnuvens.com.br/rbo/indexhttps://old.scielo.br/oai/scielo-oai.phpsob@sboportal.org.br||rbo@sboportal.org.br1982-85510034-7280opendoar:2015-11-26T00:00Revista Brasileira de Oftalmologia (Online) - Sociedade Brasileira de Oftalmologia (SBO)false |
dc.title.none.fl_str_mv |
Biomarkers and surrogate endpoints in the glaucomatous optic neuropathy: new developments and a review |
title |
Biomarkers and surrogate endpoints in the glaucomatous optic neuropathy: new developments and a review |
spellingShingle |
Biomarkers and surrogate endpoints in the glaucomatous optic neuropathy: new developments and a review Kasahara,Niro Glaucoma Optic nerve diseases Biological makers Glaucoma Doenças do nervo óptico Marcadores biológicos |
title_short |
Biomarkers and surrogate endpoints in the glaucomatous optic neuropathy: new developments and a review |
title_full |
Biomarkers and surrogate endpoints in the glaucomatous optic neuropathy: new developments and a review |
title_fullStr |
Biomarkers and surrogate endpoints in the glaucomatous optic neuropathy: new developments and a review |
title_full_unstemmed |
Biomarkers and surrogate endpoints in the glaucomatous optic neuropathy: new developments and a review |
title_sort |
Biomarkers and surrogate endpoints in the glaucomatous optic neuropathy: new developments and a review |
author |
Kasahara,Niro |
author_facet |
Kasahara,Niro |
author_role |
author |
dc.contributor.author.fl_str_mv |
Kasahara,Niro |
dc.subject.por.fl_str_mv |
Glaucoma Optic nerve diseases Biological makers Glaucoma Doenças do nervo óptico Marcadores biológicos |
topic |
Glaucoma Optic nerve diseases Biological makers Glaucoma Doenças do nervo óptico Marcadores biológicos |
description |
ABSTRACT Glaucoma is a group of progressive optic neuropathies that have in common a slow progressive degeneration of retinal ganglion cells and their axons, resulting in a distinct appearance of the optic disc and a concomitant pattern of visual loss. Biomarkers are characteristics objectively measured and evaluated as indication of normal biologic processes, pathogenic processes, or pharmacologic responses to a therapeutic intervention. Several biological markers have been implicated with glaucoma, especially genetics, proteomics, autoimmune and other molecular biomarkers, although, most awaits clinical validation. There are clear potential benefits in using biomarkers. Information can be obtained earlier, faster, and less costly. This review summarizes the latest developments and approaches in glaucoma biomarkers and its possible uses in the diagnosis, staging, and as predictors of response to treatment. |
publishDate |
2015 |
dc.date.none.fl_str_mv |
2015-08-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0034-72802015000400257 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0034-72802015000400257 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
10.5935/0034-7280.20150054 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Sociedade Brasileira de Oftalmologia |
publisher.none.fl_str_mv |
Sociedade Brasileira de Oftalmologia |
dc.source.none.fl_str_mv |
Revista Brasileira de Oftalmologia v.74 n.4 2015 reponame:Revista Brasileira de Oftalmologia (Online) instname:Sociedade Brasileira de Oftalmologia (SBO) instacron:SBO |
instname_str |
Sociedade Brasileira de Oftalmologia (SBO) |
instacron_str |
SBO |
institution |
SBO |
reponame_str |
Revista Brasileira de Oftalmologia (Online) |
collection |
Revista Brasileira de Oftalmologia (Online) |
repository.name.fl_str_mv |
Revista Brasileira de Oftalmologia (Online) - Sociedade Brasileira de Oftalmologia (SBO) |
repository.mail.fl_str_mv |
sob@sboportal.org.br||rbo@sboportal.org.br |
_version_ |
1752122337356939264 |